Effect of protein kinase C and protein kinase a inhibitors on contraction of isolated femoral arteries of SHR and Wistar rats

Physiological Research

Volumn 58, Issue 6, 2009, Pages 793-798

  Bal, M S ^a,b   Paulis, L ^b,c,d   Zicha, J ^b   Kunes J ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c Bratislava   (Slovakia)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Calcium; Femoral artery; Myograph; Protein kinase A; Protein kinase C

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; INDOLE DERIVATIVE; ISOQUINOLINE DERIVATIVE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NORADRENALIN; POTASSIUM CHLORIDE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; RO 31-8220; SULFONAMIDE; VASOCONSTRICTOR AGENT;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMORAL ARTERY; HYPERTENSION; IN VITRO STUDY; MALE; METABOLISM; PATHOPHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; CALCIUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; HYPERTENSION; INDOLES; ISOQUINOLINES; MALE; NOREPINEPHRINE; POTASSIUM CHLORIDE; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RATS, INBRED SHR; RATS, WISTAR; SULFONAMIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 77449148611     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Allemany R, Vogler O, Teres S, Egea C, Baamonde C, Barcelo F, Delgado C, Jakobs K.H, Escriba P.V: Antihypertensive action of 2-hydroxyoleic acid in SHRs via modulation of the protein kinase A pathway and Rho kinase. J Lipid Res 47: 1762-1770, 2006.
2. 2+ spark frequency in smooth muscle cells from cerebral arteries. Am J Physiol 273: C2090-C2095, 1997.
3. Budzyn K, Paull M, Marley PD, Sobey CG: Segmental differences in the roles of rho-kinase and protein kinase C in mediating vasoconstriction. J Pharmacol Exp Ther 317: 791-796, 2006.
4. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847-7851, 1982.
5. + channel-mediated responses of the basilar artery. Stroke 33: 1692-1697, 2002.
6. Conti MA, Adelstein RS: The relationship between calmodulin binding and phosphorylation of smooth muscle myosin kinase by the catalytic subunit of 3':5' cAMP-dependent protein kinase. J Biol Chem 256: 3178-3181, 1981.
7. Cox RH: Changes in the expression and function of arterial potassium channels during hypertension. Vascul Pharmacol 38: 13-23, 2002.
8. 2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt. Br J Pharmacol 143: 397-403, 2004.
9. Goldberg MT, Triggle CR: An analysis of the action of lanthanum on aortic tissue from normotensive and spontaneously hypertensive rats. Can J Physiol Pharmacol 55: 1084-1090, 1977.
10. Hermsmeyer K, Erne P: Cellular calcium regulation in hypertension. Am J Hypertens 2: 655-658, 1989.
11. Kahonen M, Arvola P, Wu X, Porsti I: Arterial contractions induced by cumulative addition of calcium in hypertensive and normotensive rats: influence of endothelium. Naunyn-Schmiedeberg's Arch Pharmacol 349: 627-636, 1994.
12. Kanashiro CA, Khalil RA: Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle. Am J Physiol 280: C34-C45, 2001.
13. Kitazawa T, Eto M, Woodsome TP, Brautigan DL: Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275: 9897-9900, 2000.
14. + channels in vascular smooth muscle cells. J Smooth Muscle Res 44: 65-81, 2008.
15. Lamounier-Zepter V, Ehrhart-Bornstein M, Karczewski P, Haase H, Bornstein SR, Morano I: Human adipocytes attenuate cardiomyocyte contraction: characterization of an adipocyte-derived negative inotropic activity. FASEB J 20: 1653-1659, 2006.
16. Lochner A, Moolman JA: The many faces of H89: a review. Cardiovasc Drug Rev 24: 261-74, 2006.
17. Lompre AM: Sarcoplasmic reticulum in vascular cells in hypertension and during proliferation. Clin Exp Pharmacol Physiol 26: 553-557, 1999.
18. Martens JR, Gelband CH: Ion channels in vascular smooth muscle: alterations in essential hypertension. Proc Soc Exp Biol Med 218: 192-203, 1998.
19. 2+ channels to contractile responses in spontaneously hypertensive rat mesenteric arteries. Am J Hypertens 10: 1231-1239, 1997.
20. 2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C. Hypertension 43: 897-904, 2004.
21. 2+ handling observed in the mesenteric arterial tree of spontaneously hypertensive rats. J Pharmacol Exp Ther 313: 359-367, 2005.
22. Nishimura J, Van Breemen C: Direct regulation of smooth muscle contractile elements by second messengers. Biochem Biophys Res Commun 163: 929-935, 1989.
23. Nishizuka Y: The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661-665, 1988.
24. Ohya Y, Tsuchihashi T, Kagiyama S, Abe I, Fujishima M: Single L-type calcium channels in smooth muscle cells from resistance arteries of spontaneously hypertensive rats. Hypertension 31: 1125-1129, 1998.
25. Paulis Ľ, Líšková S, Pintérová M, Dobešová Z, Kuneš J, Zicha J: Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment. Acta Physiol (Oxf) 191: 255-266, 2007.
26. Pratt JH, Ambrosius WT, Agarwal R, Eckert GJ, Newman S: Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension 40: 903-908, 2002.
27. Rasmussen H, Takuwa Y, Park S: Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1: 177-85, 1987.
28. 2+ channels by cyclic nucleotide cross activation of opposing protein kinases in rabbit portal vein. Circ Res 82: 557-565, 1998.
29. Salamanca DA, Khalil RA: Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension. Biochem Pharmacol 70: 1537-1547, 2005.
30. 2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C. Circ Res 91: 112-119, 2002.
31. 2++ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
32. Somlyo AP, Somlyo AV: Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
33. Somlyo A.P, Walker J.W, Goldman Y.E, Trentham D.R, Kobayashi S, Kitazawa T, Somlyo A.V: Inositol trisphosphate, calcium and muscle contraction. Philos Trans R Soc Lond B Biol Sci 320: 399-414, 1988.
34. Taguchi K, Ueda M, Kubo T: Effects of cAMP and cGMP on L-type calcium channel currents in rat mesenteric artery cells. Jpn J Pharmacol 74: 179-186, 1997.
35. 2+ signal generation. J Clin Invest 80: 248-257, 1987.
36. Wooldridge A.A, Macdonald JA, Erdodi F, M.A C, Borman M.A, Hartshorne D.J, Haystead T.A: Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides. J Biol Chem 279: 34496-34504, 2004.